Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Aspen Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (209)
ARTG (9)
Australian Public Assessment Report (AusPAR) (2)
Cancellation or suspension (2)
Prescription medicine registration (2)

Date

2024 (3)
2023 (2)
2022 (9)
2020 (11)
2019 (12)
2018 (11)
2017 (92)
2016 (35)
2015 (45)
2014 (2)
2011 (1)
2007 (1)

Results for "[search-keyword]"

Search

Sponsor content

224 result(s) found, displaying 11 to 20

SOTACOR sotalol hydrochloride 40mg/4mL injection ampoule Cancelled under Section 30(1)(c) of the Act

25 August 2022

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
Glucosamine hydrochloride 750mg Cancelled under Section 30(1)(c) of the Act

3 August 2022

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
Glucosamine Plus Cancelled under Section 30(1)(c) of the Act

3 August 2022

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
Glucosamine 625 mg Cancelled under Section 30(1)(c) of the Act

3 August 2022

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
Tranqipam 1 - South Africa (347656)

9 November 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Tranqipam 1 - South Africa.
Tranqipam 2.5 - South Africa (347657)

9 November 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Tranqipam 2.5 - South Africa.
Ural Daily Supplement High Strength Cranberry 60,000mg Cancelled under Section 30(1)(c) of the Act

2 November 2020

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
Aspen Pharma Pty Ltd - Zinc oxide eugenol dental cement (312020)

29 November 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Aspen Pharma Pty Ltd - Zinc oxide eugenol dental cement.
ASPECILLIN V Phenoxymethylpenicillin (as benzathine) 150mg/5mL oral liquid, suspension bottle Cancelled under Section 30(1)(c) of the Act

14 September 2020

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
Glucosamine Plus Chondroitin Cancelled under Section 30(1)(c) of the Act

26 June 2020

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.